Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's WhyZacks Investment Research • 09/05/23
Can Augmedix, Inc. (AUGX) Climb 36.06% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 09/04/23
Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and ComplianceGlobeNewsWire • 08/24/23
Augmedix Announces Participation in Upcoming Investor Conferences in September 2023GlobeNewsWire • 08/18/23
Wall Street Analysts See a 32.11% Upside in Augmedix, Inc. (AUGX): Can the Stock Really Move This High?Zacks Investment Research • 08/16/23
Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 08/16/23
Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023GlobeNewsWire • 08/07/23
Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023GlobeNewsWire • 07/28/23
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Augmedix, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 07/19/23
3 Medical Info Systems Stocks to Consider From a Prospering IndustryZacks Investment Research • 07/07/23
Augmedix Extends Term Loan Facility and Finalizes Terms for Equity Line of CreditGlobeNewsWire • 06/14/23
Augmedix Establishes AI Advisory Council to Guide the Company's Continued Development of High Standard, Responsible Product DevelopmentGlobeNewsWire • 06/12/23